MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Esperion Therapeutics (ESPR) Ownership - Who owns Esperion Therapeutics?

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
294
Web
https://www.esperion.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
813.02M
P/E Ratio
N/A
Total Cash
156.16M
Projected Growth
N/A
Total Debt
252.63M
Revenue
418.24M
Risk (Beta)
3.55
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
1.89 USD as % of share price
View a ticker or compare two or three
ESPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
294
Web
https://www.esperion.com